Infection of a host cell by the Herpes Simplex Virus Type 1 leads to the efficient reprogramming of the cells' synthetic machinery to replicate the viral genome ultimately producing progeny virions. Two proteins introduced upon viral fusion are thought to initiate this effect. The potent transactivator of immediate early genes (VP16) and the mRNA destabilizing virion host shutoff protein (vhs), work in concert with one another to invoke the cascade of viral gene expression, and to destroy pre-existing cellular mRNA. Due to the non-specific nature of vhs induced mRNA degradation, its activity is downregulated at later times during infection to spare virally encoded mRNA. Recent evidence has shown that VP16 is responsible for this vhs downregulation, a process thought to occur by mutual interactions between the two proteins and a potential compartmentalization of vhs within the nucleus (Lam 𝘦𝘵 𝘢𝘭., 1996; Smibert 𝘦𝘵 𝘢𝘭., 1994). Furthermore, such an event is also thought to position vhs so it can be efficiently packaged, a supposition supported by the observation that vhs lacking the ability to bind VP16 is not incorporated into new virions (Read 𝘦𝘵 𝘢𝘭. , 1993). To ascertain if VP16 was indeed capable of relocalizing vhs to the nucleus of a cell in the absence of any other viral factors, we created multiple constructs consisting of various portions of vhs fused in frame to the fluorescent marker protein EGFP. In addition, various truncated forms of VP16 were also fused to EGFP for the purpose of delineating the region of VP16 that is responsible for VP16 and possibly vhs nuclear localization. Co-transfection experiments utilizing EGFP-vhs fusions demonstrated that vhs relocalizes to perinuclear regions in the presence of VP16, an effect absolutely dependent upon its ability to interact with VP16. In addition, deletion mapping of VP16 implicated the region spanning amino acids 335 to 355 as being necessary for this localization, with a stretch of 15 amino acids (330 to 344) appearing to constitute a putative bipartite nuclear localization signal. Interestingly, our observation that the vhs/VP16 complex localizes to a region of the cell thought to ultimately encompass the tegument of new virions gives credence to the notion that this interaction and subsequent localization may indeed function to package vhs into new virions. Furthermore, it is also suggested that vhs may in fact be downregulated at intermediate times during infection through VP16 mediated compartmentalization within the nucleus. For these reasons we propose that the disruption of the vhs/VP16 interaction could severely abrogate the infectivity of HSV and as such could present a novel target for antiviral intervention. / Thesis / Master of Science (MS)

In CBA/NJ mice, splenic natural killer (NK) cell activity varies with stages of estrous. Susceptibility of ICR mice to intravaginal inoculation of herpes simplex virus type 2 (HSV-2) decreases with age. Susceptibility of female ICR and CBA/NJ mice to HSV-2 inoculated intravaginally and intraperitoneally was examined during the estrous cycle. In cycling ICR mice, greatest susceptibility to intravaginal inoculation was observed during diestrous and the least during metestrous. CBA/NJ mice were most susceptible to intravaginal inoculation of HSV-2 during diestrous. ICR mice were ovariectomized to mimic diestrous and found to be highly susceptible to intravaginal inoculation at all virus doses. No difference in susceptibility among phases of the estrous cycle was seen following intraperitoneal inoculation.

Thesis (Ph. D.)--University of Sydney, 2005. / Title from title screen (viewed 20 May 2008). Submitted in fulfilment of the requirements for the degree of Doctor of Philosophy to the Faculty of Medicine. Degree awarded 2005; thesis originally submitted 2004, corrected version submitted April 2005. Includes bibliographical references. Also available in print form.

Ocorrências comuns de infecções virais graves, aparecimento de cepas resistentes e um limitado número de quimioterápicos antivirais disponíveis mostram a necessidade da busca por novas substâncias ativas como antivirais. Muitas substâncias derivadas de plantas são candidatas ao estudo do seu potencial na terapia sistêmica e/ou profilaxia de herpes simplex virus 1 (HSV-1). Dentre as plantas com atividade antiviral, destacam-se as do gênero Baccharis. O objetivo geral do trabalho foi o estudo da composição química e avaliação da atividade antiviral das folhas de Baccharis anomala D.C. através de fracionamento bioguiado. Utilizando precipitação com etanol e fracionamento por permeação molecular foi possível separar os constituintes químicos ativos contra o vírus HSV-1 presentes no extrato aquoso de Baccharis anomala. Os testes de prospecção de constituintes químicos indicaram a presença de taninos, catequinas e saponinas no extrato aquoso da espécie. Através da análise cromatográfica foi possível detectar a presença de compostos fenólicos, utilizando-se coloração com cloreto férrico e reagente natural. Em relação à atividade antiviral, a fração ativa denominada AQ PPT FR 4-5 apresentou pronunciada atividade antiviral, inibindo a replicação viral em 100 % nas concentrações de 1,25, 0,625, 0,312 e 0,156 mg/mL, contra as cepas ATCC-VR733 e Aciclovir-resistente 29-R do HSV-1. Em relação ao mecanismo de ação, observou-se atividade virucida da fração AQ PPT FR 4-5. Estes resultados são muito importantes, pois, de acordo com a literatura, ainda não foram relatados compostos com atividade virucida úteis clinicamente para o tratamento de infecções por HSV-1. Conclui-se, portanto, que Baccharis anomala possui potente atividade antiviral contra o vírus HSV-1 e é promissora para estudos posteriores que visem ao isolamento, identificação e estudo do mecanismo de ação antiviral de compostos ativos da espécie, considerando a emergência de cepas resistentes e a necessidade de compostos com novos mecanismos de ação. / Common occurrences of severe viral infections, emergence of resistant strains and a limited number of available antiviral chemotherapeutics show the need to search for new active substances as antiviral. Many compounds derived from plants are candidates for the study of their potential in systemic therapy and/or prophylaxis of herpes simplex virus type 1 (HSV-1). Among the plants with antiviral activity, those from the genus Baccharis are remarkable. The main objective of the work was the study of the chemical composition and evaluation of the antiviral activity of extracts from Baccharis anomala D.C., using bioactivity guided fractionation. Through precipitation with ethanol and fractionation by molecular permeation it was achieved the separation of the active chemical constituents against HSV-1 virus in the aqueous extract of Baccharis anomala. Phytochemical tests indicated the presence of tannins, catechins and saponins in the aqueous extract. By thin layer chromatography it was detected the presence of phenolic compounds using ferric chloride and natural reagent. Concerning the antiviral activity, the active fraction named AQ PPT FR 4-5 showed pronounced antiviral activity, represented by 100 % inhibition of viral replication at concentrations of 1.25, 0.625, 0.312 and 0.156 mg/mL, against the strains ATCC-VR733 and Acyclovir-resistant 29-R of HSV-1 virus. Regarding the mechanism of action, virucidal activity on the fraction AQ PPT FR 4-5 was detected, which is also very important because, as far as we know, compounds with virucidal activity for clinical use in the treatment of HSV-1 infections were not reported yet. In conclusion, Baccharis anomala displayed pronounced antiviral activity against HSV-1 virus and it is promising for further studies aimed to the isolation, identification and mechanism of action of antiviral active compounds of the species, considering the emergence of resistant strains and the need for compounds with new mechanisms of action.

Ocorrências comuns de infecções virais graves, aparecimento de cepas resistentes e um limitado número de quimioterápicos antivirais disponíveis mostram a necessidade da busca por novas substâncias ativas como antivirais. Muitas substâncias derivadas de plantas são candidatas ao estudo do seu potencial na terapia sistêmica e/ou profilaxia de herpes simplex virus 1 (HSV-1). Dentre as plantas com atividade antiviral, destacam-se as do gênero Baccharis. O objetivo geral do trabalho foi o estudo da composição química e avaliação da atividade antiviral das folhas de Baccharis anomala D.C. através de fracionamento bioguiado. Utilizando precipitação com etanol e fracionamento por permeação molecular foi possível separar os constituintes químicos ativos contra o vírus HSV-1 presentes no extrato aquoso de Baccharis anomala. Os testes de prospecção de constituintes químicos indicaram a presença de taninos, catequinas e saponinas no extrato aquoso da espécie. Através da análise cromatográfica foi possível detectar a presença de compostos fenólicos, utilizando-se coloração com cloreto férrico e reagente natural. Em relação à atividade antiviral, a fração ativa denominada AQ PPT FR 4-5 apresentou pronunciada atividade antiviral, inibindo a replicação viral em 100 % nas concentrações de 1,25, 0,625, 0,312 e 0,156 mg/mL, contra as cepas ATCC-VR733 e Aciclovir-resistente 29-R do HSV-1. Em relação ao mecanismo de ação, observou-se atividade virucida da fração AQ PPT FR 4-5. Estes resultados são muito importantes, pois, de acordo com a literatura, ainda não foram relatados compostos com atividade virucida úteis clinicamente para o tratamento de infecções por HSV-1. Conclui-se, portanto, que Baccharis anomala possui potente atividade antiviral contra o vírus HSV-1 e é promissora para estudos posteriores que visem ao isolamento, identificação e estudo do mecanismo de ação antiviral de compostos ativos da espécie, considerando a emergência de cepas resistentes e a necessidade de compostos com novos mecanismos de ação. / Common occurrences of severe viral infections, emergence of resistant strains and a limited number of available antiviral chemotherapeutics show the need to search for new active substances as antiviral. Many compounds derived from plants are candidates for the study of their potential in systemic therapy and/or prophylaxis of herpes simplex virus type 1 (HSV-1). Among the plants with antiviral activity, those from the genus Baccharis are remarkable. The main objective of the work was the study of the chemical composition and evaluation of the antiviral activity of extracts from Baccharis anomala D.C., using bioactivity guided fractionation. Through precipitation with ethanol and fractionation by molecular permeation it was achieved the separation of the active chemical constituents against HSV-1 virus in the aqueous extract of Baccharis anomala. Phytochemical tests indicated the presence of tannins, catechins and saponins in the aqueous extract. By thin layer chromatography it was detected the presence of phenolic compounds using ferric chloride and natural reagent. Concerning the antiviral activity, the active fraction named AQ PPT FR 4-5 showed pronounced antiviral activity, represented by 100 % inhibition of viral replication at concentrations of 1.25, 0.625, 0.312 and 0.156 mg/mL, against the strains ATCC-VR733 and Acyclovir-resistant 29-R of HSV-1 virus. Regarding the mechanism of action, virucidal activity on the fraction AQ PPT FR 4-5 was detected, which is also very important because, as far as we know, compounds with virucidal activity for clinical use in the treatment of HSV-1 infections were not reported yet. In conclusion, Baccharis anomala displayed pronounced antiviral activity against HSV-1 virus and it is promising for further studies aimed to the isolation, identification and mechanism of action of antiviral active compounds of the species, considering the emergence of resistant strains and the need for compounds with new mechanisms of action.

Ocorrências comuns de infecções virais graves, aparecimento de cepas resistentes e um limitado número de quimioterápicos antivirais disponíveis mostram a necessidade da busca por novas substâncias ativas como antivirais. Muitas substâncias derivadas de plantas são candidatas ao estudo do seu potencial na terapia sistêmica e/ou profilaxia de herpes simplex virus 1 (HSV-1). Dentre as plantas com atividade antiviral, destacam-se as do gênero Baccharis. O objetivo geral do trabalho foi o estudo da composição química e avaliação da atividade antiviral das folhas de Baccharis anomala D.C. através de fracionamento bioguiado. Utilizando precipitação com etanol e fracionamento por permeação molecular foi possível separar os constituintes químicos ativos contra o vírus HSV-1 presentes no extrato aquoso de Baccharis anomala. Os testes de prospecção de constituintes químicos indicaram a presença de taninos, catequinas e saponinas no extrato aquoso da espécie. Através da análise cromatográfica foi possível detectar a presença de compostos fenólicos, utilizando-se coloração com cloreto férrico e reagente natural. Em relação à atividade antiviral, a fração ativa denominada AQ PPT FR 4-5 apresentou pronunciada atividade antiviral, inibindo a replicação viral em 100 % nas concentrações de 1,25, 0,625, 0,312 e 0,156 mg/mL, contra as cepas ATCC-VR733 e Aciclovir-resistente 29-R do HSV-1. Em relação ao mecanismo de ação, observou-se atividade virucida da fração AQ PPT FR 4-5. Estes resultados são muito importantes, pois, de acordo com a literatura, ainda não foram relatados compostos com atividade virucida úteis clinicamente para o tratamento de infecções por HSV-1. Conclui-se, portanto, que Baccharis anomala possui potente atividade antiviral contra o vírus HSV-1 e é promissora para estudos posteriores que visem ao isolamento, identificação e estudo do mecanismo de ação antiviral de compostos ativos da espécie, considerando a emergência de cepas resistentes e a necessidade de compostos com novos mecanismos de ação. / Common occurrences of severe viral infections, emergence of resistant strains and a limited number of available antiviral chemotherapeutics show the need to search for new active substances as antiviral. Many compounds derived from plants are candidates for the study of their potential in systemic therapy and/or prophylaxis of herpes simplex virus type 1 (HSV-1). Among the plants with antiviral activity, those from the genus Baccharis are remarkable. The main objective of the work was the study of the chemical composition and evaluation of the antiviral activity of extracts from Baccharis anomala D.C., using bioactivity guided fractionation. Through precipitation with ethanol and fractionation by molecular permeation it was achieved the separation of the active chemical constituents against HSV-1 virus in the aqueous extract of Baccharis anomala. Phytochemical tests indicated the presence of tannins, catechins and saponins in the aqueous extract. By thin layer chromatography it was detected the presence of phenolic compounds using ferric chloride and natural reagent. Concerning the antiviral activity, the active fraction named AQ PPT FR 4-5 showed pronounced antiviral activity, represented by 100 % inhibition of viral replication at concentrations of 1.25, 0.625, 0.312 and 0.156 mg/mL, against the strains ATCC-VR733 and Acyclovir-resistant 29-R of HSV-1 virus. Regarding the mechanism of action, virucidal activity on the fraction AQ PPT FR 4-5 was detected, which is also very important because, as far as we know, compounds with virucidal activity for clinical use in the treatment of HSV-1 infections were not reported yet. In conclusion, Baccharis anomala displayed pronounced antiviral activity against HSV-1 virus and it is promising for further studies aimed to the isolation, identification and mechanism of action of antiviral active compounds of the species, considering the emergence of resistant strains and the need for compounds with new mechanisms of action.

Submitted by Biblioteca da Faculdade de Farmácia (bff@ndc.uff.br) on 2018-01-11T13:56:55Z No. of bitstreams: 1 FIORELLA ZIBETTI.pdf: 1848554 bytes, checksum: a4058071f9ee8b5dc5ab5c3abb07a729 (MD5) / Made available in DSpace on 2018-01-11T13:56:55Z (GMT). No. of bitstreams: 1 FIORELLA ZIBETTI.pdf: 1848554 bytes, checksum: a4058071f9ee8b5dc5ab5c3abb07a729 (MD5) / O óleo essencial de Rosmarinus officinalis (OERo) possui atividade anti- herpética in vitro. Entretanto, os constituintes químicos estão sujeitos à degradação por oxidação ou volatilização. Desta forma, surge a necessidade de desenvolvimento de sistemas carreadores para este ativo vegetal. O presente trabalho teve como objetivo desenvolver nanoemulsões contendo OERo, comparando dois métodos de baixo aporte energético, titulação à frio e inversão de fases, quanto à estabilidade, teor do marcador químico, perfil de liberação in vitro, permeação e retenção cutânea in vitro e atividade anti-herpética in vitro. O OERo, utilizado nesse estudo, apresentou como constituinte majoritário o eucaliptol (27,9%), descrito na literatura por inibir o vírus Herpes simplex. As nanoemulsões e seus respectivos hidrogéis foram desenvolvidos e conservados em temperatura ambiente por 60 dias. Todas as formulações mantiveram-se estáveis durante o período estudado, apresentando tamanho de gotícula inferior a 200nm. Nenhum dos parâmetros avaliados apresentou diferença significativa entre os métodos utilizados, com exceção do teor, que foi menor em T0 nas nanoemulsões produzidas com aquecimento. Aas formulações apresentaram cerca de 60% de liberação do óleo em 150 minutos em ensaio in vitro. No estudo de permeação/retenção cutânea in vitro foi possível detectar o eucaliptol, por Cromatografia Líquida de Alta Eficiência, no meio de lavagem (~32%), estrato córneo (~12%) e meio receptor (~56%), não sendo observado na epiderme e derme. Para avaliação da atividade anti-herpética, as nanoemulsões apresentaram índice de inibição viral superior a 98,2% (HSV-1) e 99,5% (HSV- 2), apresentando maior especificidade pelo sorotipo 2. As diferentes metodologias não impactaram significativamente na atividade anti-herpética. Dessa forma, conclui-se que ambos os métodos são capazes de preparar nanoemulsões com características semelhantes e estudos in vivo serão necessários para melhor entendimento da atividade do óleo / The essential oil of Rosmarinus officinalis (OERo) has anti-herpetic activity in vitro. However, the chemical constituents are subject to degradation by oxidation or volatilization. Thus, indicating a need to develop carriers systems for this plant active.The aim of the present work was to develop nanoemulsions containing OERo, comparing two low energy methods, cold titration and phase inversion, in terms of stability, chemical marker content, in vitro release profile, in vitro skin permeation and retention, and anti-herpetic activity in vitro. The OERo used in this study presented as main constituent eucalyptol (27.9%), which was described in the literature for inhibiting the Herpes simplex virus. Nanoemulsions and their respective hydrogels were developed by two different methodologies and stored at room temperature for 60 days. All formulations remained stable during the study period, with particle size smaller than 200nm. None of the parameters evaluated showed a significant difference between the methods used, except for the chemical marker content, which was lower in T0 for the nanoemulsions prepared with heating. The in vitro release profile of the formulations showed 60% oil release in 150 minutes. In the in vitro skin permeation / retention study, it was possible to detect eucalyptol, by High Performance Liquid Chromatography, in washing liquid (~32%), stratum corneum (~12%) and receiving liquid (~56%), but none was detected in epidermis and dermis. In order to evaluate the anti-herpetic activity, the nanoemulsions showed a viral inhibition index higher than 98.2% (HSV-1) and 99.5% (HSV-2), presenting a better specificity for serotype 2. Despite the loss of volatile constituents of the oil by heating, the different methodologies did not significantly impact the antiherpetic activity. Thus, it could be concluded that both low-energy methods are able to prepare nanoemulsions with similar characteristics and it is necessary further studies to better understand the oil activity

No description available.

No description available.

M.P.H., Faculty of Health Sciences, University of the Witwatersrand, 2009 / Background: Herpes Simplex Virus type 2 (HSV-2) is a common cause of genital ulcers worldwide and has emerged as a co-factor in human immunodeficiency virus (HIV) acquisition and transmission. A study was conducted to determine the prevalence of HSV-2, its correlates, the accuracy of reported history of genital ulcer disease (GUD) to predict HSV-2 infection and the extent of symptom recognition in a clinic population in Johannesburg. Methods: 210 women aged 18 years or older were interviewed and socio-demographic, sexual behaviour and clinical information collected. Serological testing for HSV-2 and HIV infections was performed, but only where sera were available for the latter. Factors associations with HSV-2 infection were assessed using logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI). The sensitivity, specificity, predictive values and likelihood ratios of a history of GUD were calculated. Results: The estimated sero prevalence of HSV-2 was 73% (95% CI 67% - 79%). Few participants, 13/206 (6%) participants had knowledge of genital herpes. Only 9/203 (4%) participants recognised lesions of genital herpes following education and counselling about HSV-2 infection. HSV-2 infection was associated with older age(>25 years of age) OR 2.6 (95% CI 1.4-5.0), spending more than 2 nights away from home, OR 6.0 (95% CI 1.0-62.7), having more than 2 sexual lifetime partners, OR 2.2 (95% CI 1.1-3.9), a history of an STI in the past 3 months ,OR 3.6 (95% CI 1.2-9.5) and HIV infection, OR3.3( 95%CI 1.4-7.9). A history of genital ulceration performed poorly as a predictor of HSV-2 seropositivity; the sensitivity was 7% and specificity was 96%. Conclusion: HSV-2 prevalence was high and few participants were aware of their infection. HVS-2 infection was associated with risky sexual behaviour .A history of genital ulcer disease was not sufficient as a diagnostic tool for HSV-2 infection. Public health interventions should focus on behavioural modification and increasing awareness of genital herpes. HSV-2 management should be incorporated into HIV care and STI protocols.